Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Antares Pharma, Inc.

ATRS•NASDAQ
Healthcare
Medical - Instruments & Supplies
$5.59
$0.010(0.18%)
U.S. Market opens in 15h 52m

Antares Pharma, Inc. (ATRS) Stock Overview

Explore Antares Pharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio20.55
EPS (TTM)$0.37
ROE0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$6.00
3 MonthsN/A
1 Year Target$7.27

ATRS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Antares Pharma, Inc. (ATRS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $7.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.55 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
98.23%
All-Time (Max) Change
69.39%

Contact Information

https://www.antarespharma.com
16093593020
SUITE 300, 100 PRINCETON SOUTH, Ewing, NJ, 08628

Company Facts

2,010 Employees
IPO DateOct 3, 1996
CountryUS

Frequently Asked Questions